Home » Topics » BioWorld Science

BioWorld Science
RSS

Repurposing bumetanide for the treatment of APOE4-related AD

Oct. 26, 2021

CS-5001, novel ADC with promising efficacy in models of ROR1-expressing cancers

Oct. 26, 2021

New human SARS-CoV-2 vaccines based on AAV vectors presented

Oct. 26, 2021

The gut microbiota affects CRPC growth by contributing to androgen metabolism

Oct. 26, 2021

Therapeutic profiling unveils three functional subtypes of cancer-associated fibroblasts in NSCLC

Oct. 26, 2021

Sangamo presents IL23R-CAR-Tregs for treating Crohn's disease

Oct. 26, 2021

Gene-protein-disease map reveals connections within and between diseases

Oct. 25, 2021

ABHD16A deficiency linked to subtype of complicated hereditary spastic paraplegia

Oct. 25, 2021

Novel PSMA-targeting ligand PSMA-TO-1 shows prolonged circulation time and higher tumor uptake

Oct. 25, 2021

AAV9-Galns gene therapy corrects mucopolysaccharidosis type IVA pathology in vivo

Oct. 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...